Abstract

Theoretical investigation of the acoustic responses of albumin‐encapsulated microspheres began over fifteen years ago when Albunex, the first agent approved for clinical use in the US, was still in development. Since that time, the number of potential ultrasound contrast agents has grown considerably. Depending on the agent, the shell may comprise a layer of proteins, synthetic polymers, surfactants, or lipids with a thickness from a few nm to 500 mm and surrounding air, sulfur hexafluoride, perfluorocarbon, or other gas. A thorough understanding of the interaction between ultrasound pulses and contrast microbubbles is essential for the successful clinical application of a particular agent. In this talk, the behavior of various contrast agents will be discussed, and appropriate models for each will be described. The basis for each of these theories is a free bubble model supplemented by the effect of the encapsulating shell. The differences among these models lie primarily in their treatment of the enca...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.